CLEANClean Science and Technology Limited Forensic Risk Analysis

Specialty Chemicals
Risk ClassModerate Deterioration
Market Cap₹7,886 Cr
Primary DriverEarnings Quality
Flagium AI Risk Score
Moderate stress emerging. While not critical, underlying pressure is building.
40 / 100
+5 QoQ
Deteriorating
Sentinel Insight

Some early signs of pressure are visible. Weakness is detected in profitability and earnings quality. This suggests a building risk profile. Risk is increasing at a faster pace.

98.0th %ile (Sector)Accel: +3 Qtrs
Updated2026-06-02
Market View
₹783.15▼0.57%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Earnings Quality
+15.0 pts
Competitive Position
+15.0 pts
Growth Sustainability
+10.0 pts
Final Composite Risk40 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 5 → 40 over 13 quarters.

Expected Direction
🚨 Escalate
Primary Deterioration Drivers
  • Margin Compression
  • Inventory Stress
  • Relative Growth Weakness
What to Watch Next Quarter
  • Operating profit margins
  • Debt growth
  • Inventory turnover

Active Risk Objects (6)

CriticalHigh
Margin Compression
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight15/15
MomentumPersistent
Last SignalQ4 FY2026
Operating margin declined by 5.3 bps YoY for two consecutive quarters.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Relative Growth Weakness
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight12/15
MomentumAccelerating
Last SignalQ4 FY2026
Revenue growth consistently lags behind sector median (12.8%).

"Early signs of earnings quality decay. Profitability is being driven by non-core items."

Capex Efficiency Stress
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight8/15
MomentumAccelerating
Last SignalQ2 FY2026
Aggressive Capex (37.6%) amidst slow revenue growth (0.8%).

"Earnings quality is under severe pressure. High accruals suggest potential revenue overstatement."

Operating Leverage Stress
📉 Trend DeteriorationAnnualActive for 5 Years
More Detail
Impact Weight10/15
MomentumPersistent
Last SignalQ4 FY2026
Expenses are consistently growing faster than revenues, creating operational pressure.

"The balance sheet is heavily over-leveraged. Interest payments are consuming most of the profit."

Inventory Stress
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight15/15
MomentumPersistent
Last SignalQ4 FY2026
Inventory growth (2.9%) significantly outpaced revenue growth (-8.7%).

"Stock is piling up in the warehouse. Inventory turnover is slowing down dangerously."

Cash Conversion Deficit
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight6/15
MomentumPersistent
Last SignalFY2026
CLEAN: OCF below Net Profit in 2/3 recent years.

"Cash conversion is dangerously low. Operational cash flow is significantly trailing reported PAT."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)5.4210.68✅ RESILIENT
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+26.0+46.0📈 CRITICAL
Forensic Benchmark Context: Specialty Chemicals (n=51 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
₹783.15(-0.57%)
1M Divergence-6.65%
1 Week+4.8%
1 Month-4.38%
6 Months-11.85%
1 Year-47.69%
2 Year-39.5%
3 Year-43.73%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The risk profile is Moderate Stress and currently deteriorating. Recent structural triggers in earnings quality suggest a building pressure on the underlying framework. Material forensic traces are visible in operational margins and profitability metrics, indicating a progressive erosion of structural stability. Strategic vigilance is advised as structural decay is accelerating.

CLEAN • MARKET STRUCTURE

Stage 4 — Declining

The company is in a defensive phase. Sentiment and fundamentals are deteriorating under persistent downward pressure, indicating elevated risk levels.

Stage Transition Prob.0%
Trend QualityDeteriorating
Phase Progression
Phase Progression Score7.5%
Readiness LabelLow (Early Base Consolidation)
Probability of Advancing0%
CoinTree Momentum
Composite Z-Score-0.1944σ
Weakening momentum trend
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#1398 of 2716
Top 51.47% in momentum strength
Timeframe Sparklines
1W+4.8%
1M-4.4%
6M-11.8%
Weinstein Indicators
150 DMA₹828.14
200 DMA₹903.31
150 DMA Slope-4.2573%Declining
Relative Strength-6.36%Lagging
Relative Turnover (RTR)1.0077
ParticipationNeutral

PEER COMPARISON

Ranked comparison against sector peers

This company shows higher risk compared to the Sector Mean (20).
AARTIINDAarti Industries Limited
20 Risk
Sector %ile46th
Delta-5
Active Flags24
Accel+0
Balance Sheet Stress

Watch

ACIArchean Chemical Industries Limited
35 Risk
Sector %ile84th
Delta+20
Active Flags22
Accel+1
Earnings Quality

Watch

CLEANClean Science and Technology Limited
40 Risk
Sector %ile98th
Delta+5
Active Flags6
Accel+3
Earnings Quality

Moderate Deterioration

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
00th %ile
VS Sector Median (8.5)
Balance Sheet Stress
10100th %ile
VS Sector Median (8.5)
Competitive Position
00th %ile
VS Sector Median (8.5)
Growth Sustainability
00th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Operating Leverage Stress

2026

Margin Compression

2026

Relative Growth Weakness

2026

Inventory Stress

2026

Operating Leverage Stress

2026

Margin Compression

2026

Relative Growth Weakness

2026

Operating Leverage Stress

2026

Inventory Stress

2026

Capex Efficiency Stress

2026

Operating Leverage Stress

2026

Cash Conversion Deficit

2025

Operating Leverage Stress

2025

Margin Compression

2025

Cash Conversion Deficit

2024

Inventory Stress

2024

Capex Efficiency Stress

2024

Cash Conversion Deficit

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY2026989230275-
FY20251,005264214-
FY2024833244237-
FY20239662952790